FDA Approved: VIVIMUSTA — Supplemental Application (Azurity Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for VIVIMUSTA (bendamustine hydrochloride) filed by Azurity Pharmaceuticals, Inc., to update/expand the approved pro…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Follicular Lymphoma
• Mantle Cell Lymphoma
• Marginal Zone Lymphoma
• Non-hodgkin Lymphoma
• Small Lymphocytic Lymphoma

Drugs mentioned

• VIVIMUSTA (BENDAMUSTINE HYDROCHLORIDE)

Snippet

SUPPL AP for VIVIMUSTA (BENDAMUSTINE HYDROCHLORIDE)